Navigation Links
Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
Date:11/24/2009

SAN DIEGO, Nov. 24 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 21st Annual Piper Jaffray Health Care Conference in New York.

The live presentation takes place Tuesday, December 1, 2009 at 4:30 p.m. Eastern Time (ET)/1:30 p.m. Pacific Time (PT). The presentation will be simultaneously webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

SOURCE Neurocrine Biosciences, Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences Reports Third Quarter 2009 Results
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
3. Neurocrine Biosciences Presents Elagolix Data
4. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
5. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
6. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
7. Neurocrine Biosciences Reports First Quarter 2008 Results
8. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
9. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
10. Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results
11. Cell Biosciences Completes Acquisition of Alpha Innotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015  Landauer, Inc. (NYSE: ... environmental radiation measurement and monitoring, outsourced medical physics services ... will release financial results for the fiscal first quarter ... 2015. The Company will also host ... 2015 at 9:00 a.m. Central Time (10:00 a.m. Eastern ...
(Date:3/2/2015)...  Actavis plc (NYSE: ACT ) ... offerings of 14,513,889 Ordinary Shares at $288.00 per ... Series A, at $1,000.00 per share, each having ... The amounts sold include 1,319,444 Ordinary Shares and ... the exercise in full of the over-allotment option ...
(Date:3/2/2015)... Utah , March 2, 2015  BC ... Imaging Solutions, has acquired Eclipse Systems, a Nuclear ... service solutions. As part of their ongoing vision ... at an affordable rate, BC Technical continues to ... allows BC Technical to add valuable resources and ...
Breaking Medicine Technology:Landauer, Inc. Announces Date and Time for Announcement of Fiscal First Quarter 2015 Results and Conference Call 2Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 2Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 3Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 4Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 5Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 6Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 7Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 8BC Technical Acquires Eclipse Systems 2
(Date:3/2/2015)... NY (PRWEB) March 02, 2015 ... Administration (FDA) warned against the use of power ... and fibroid removal surgeries, insurer UnitedHealthCare is poised ... use of those devices. In a notification sent ... beginning in April, it would require pre-authorization for ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 ZoomCare ... to remake American healthcare. Zoom will expand its ... neighborhood clinics and advanced care studios delivering urgent ... emergency services, specialty care and outpatient surgery. With ... access to almost all healthcare needs outside of ...
(Date:3/2/2015)... York (PRWEB) March 02, 2015 ... at Recovery Unplugged™—will be delivering a plenary address ... Perspective on the Art of Healing and Recovery ... (NCAD) and Behavioral Healthcare Executive Summit (BHES).     , ... Mr. Supa’s songs have been recorded by some ...
(Date:3/2/2015)... NY (PRWEB) March 02, 2015 This year, ... March 2–8 and will provide opportunities for people across the ... ways to help people with MS live their best lives. ... made and to inspire others to join the Society’s vision ... sclerosis, an unpredictable, often disabling disease of the central nervous ...
(Date:3/2/2015)... 2015 Regulatory Compliance Associates® Inc. ... regulatory and technical consulting, announces Mr. Seyed Khorashahi ... , Before joining RCA, Mr. Khorashahi had ... in all aspects of developing safety-critical medical devices. ... (Medtronic), Regulatory Compliance Associates Inc., Baxter Healthcare, and ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 4Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2
... rates reach the highest levels in 16 years, a ... laid-off workersonly 9 percenttook up coverage under the Consolidated ... who also lose their health insurance would need substantial ... health insurance premiums, for their premium contributions to remain ...
... Incidents were reported by half of family caretakers surveyed in ... than half of family members looking after people with dementia ... British study finds. , Actual physical abuse was rare, being ... study. But the researchers, who published their findings in ...
... 22 The following is a statement from United ... Hearing Officer Ray Marshall ruled against a ... of the Service Employees International Union in 1921 that ... right to take over a local union. Even with ...
... T. Allison, FACHE, president/CEO of Baylor Health Care System ... the Texas Hospital Association,s Earl M. Collier Award for ... Award is the highest honor bestowed by THA. Allison ... Leadership Conference in Austin."Joel Allison exemplifies the leadership qualities ...
... MADISON, N.J., Jan. 22 At a meeting of its ... ) declared dividends on both the Common and Preferred Stock ... on the outstanding shares of Common Stock was declared payable ... close of business on February 13, 2009. In addition, ...
... WASHINGTON, Jan. 22 Speaker Nancy Pelosi released ... 36th Anniversary of Roe v. Wade:"On the 36th ... commitment to protecting a woman,s right to make ... just two days after swearing in a new ...
Cached Medicine News:Health News:Only about one of ten unemployed workers obtain COBRA coverage 2Health News:Many Alzheimer's Caregivers Admit to Abusive Behavior 2Health News:Many Alzheimer's Caregivers Admit to Abusive Behavior 3Health News:UHW Statement on Ray Marshall Trusteeship Recommendations 2Health News:Allison Honored with Hospital Association's Highest Award 2Health News:Allison Honored with Hospital Association's Highest Award 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: